Semiconductors
Compare Stocks
5 / 10Stock Comparison
IMOS vs ONTO vs COHU vs FORM vs ICHR
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
IMOS vs ONTO vs COHU vs FORM vs ICHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $2.07B | $13.63B | $2.23B | $11.28B | $2.47B |
| Revenue (TTM) | $22.81B | $1.03B | $481M | $840M | $959M |
| Net Income (TTM) | $247M | $106M | $-56M | $68M | $-51M |
| Gross Margin | 9.5% | 48.8% | 25.7% | 42.1% | 11.3% |
| Operating Margin | 2.7% | 10.0% | -10.6% | 12.7% | -3.8% |
| Forward P/E | 0.8x | 38.7x | 89.2x | 66.5x | 62.2x |
| Total Debt | $15.16B | $17M | $359M | $45M | $186M |
| Cash & Equiv. | $15.22B | $346M | $227M | $103M | $98M |
IMOS vs ONTO vs COHU vs FORM vs ICHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ChipMOS TECHNOLOGIE… (IMOS) | 100 | 291.9 | +191.9% |
| Onto Innovation Inc. (ONTO) | 100 | 881.7 | +781.7% |
| Cohu, Inc. (COHU) | 100 | 315.3 | +215.3% |
| FormFactor, Inc. (FORM) | 100 | 574.8 | +474.8% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 313.1 | +213.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IMOS vs ONTO vs COHU vs FORM vs ICHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IMOS carries the broadest edge in this set and is the clearest fit for income & stability and valuation efficiency.
- Dividend streak 0 yrs, beta 1.36, yield 1.9%
- PEG 0.01 vs ONTO's 1.12
- Lower P/E (0.8x vs 62.2x)
- Beta 1.36 vs ICHR's 3.93
ONTO ranks third and is worth considering specifically for quality.
- 10.3% margin vs COHU's -11.5%
COHU is the clearest fit if your priority is growth exposure and defensive.
- Rev growth 12.7%, EPS growth -6.7%, 3Y rev CAGR -17.7%
- Beta 2.13, current ratio 6.88x
- 12.7% revenue growth vs ONTO's 1.8%
FORM is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 19.5% 10Y total return vs ONTO's 14.3%
- Lower volatility, beta 2.02, Low D/E 4.3%, current ratio 4.50x
- +387.8% vs ONTO's +118.9%
- 5.6% ROA vs ICHR's -5.2%, ROIC 5.4% vs -3.9%
Among these 5 stocks, ICHR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.7% revenue growth vs ONTO's 1.8% | |
| Value | Lower P/E (0.8x vs 62.2x) | |
| Quality / Margins | 10.3% margin vs COHU's -11.5% | |
| Stability / Safety | Beta 1.36 vs ICHR's 3.93 | |
| Dividends | 1.9% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +387.8% vs ONTO's +118.9% | |
| Efficiency (ROA) | 5.6% ROA vs ICHR's -5.2%, ROIC 5.4% vs -3.9% |
IMOS vs ONTO vs COHU vs FORM vs ICHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
IMOS vs ONTO vs COHU vs FORM vs ICHR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
IMOS leads in 2 of 6 categories
ONTO leads 1 • FORM leads 1 • ICHR leads 1 • COHU leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — ONTO and FORM each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IMOS is the larger business by revenue, generating $22.8B annually — 47.4x COHU's $481M. ONTO is the more profitable business, keeping 10.3% of every revenue dollar as net income compared to COHU's -11.5%. On growth, FORM holds the edge at +32.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $22.8B | $1.0B | $481M | $840M | $959M |
| EBITDAEarnings before interest/tax | $5.6B | $158M | -$11M | $152M | -$11M |
| Net IncomeAfter-tax profit | $247M | $106M | -$56M | $68M | -$51M |
| Free Cash FlowCash after capex | -$85M | $239M | $32M | -$5M | -$17M |
| Gross MarginGross profit ÷ Revenue | +9.5% | +48.8% | +25.7% | +42.1% | +11.3% |
| Operating MarginEBIT ÷ Revenue | +2.7% | +10.0% | -10.6% | +12.7% | -3.8% |
| Net MarginNet income ÷ Revenue | +1.1% | +10.3% | -11.5% | +8.1% | -5.3% |
| FCF MarginFCF ÷ Revenue | -0.4% | +23.2% | +6.6% | -0.6% | -1.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.2% | +9.5% | +29.3% | +32.0% | +4.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +22.0% | -48.5% | +60.6% | +2.2% | +46.2% |
Valuation Metrics
IMOS leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 48.2x trailing earnings, IMOS trades at a 77% valuation discount to FORM's 209.7x P/E. Adjusting for growth (PEG ratio), IMOS offers better value at 0.77x vs ONTO's 2.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.1B | $13.6B | $2.2B | $11.3B | $2.5B |
| Enterprise ValueMkt cap + debt − cash | $2.1B | $13.3B | $2.4B | $11.2B | $2.6B |
| Trailing P/EPrice ÷ TTM EPS | 48.23x | 98.57x | -29.86x | 209.68x | -46.25x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.80x | 38.74x | 89.21x | 66.48x | 62.25x |
| PEG RatioP/E ÷ EPS growth rate | 0.77x | 2.85x | — | — | — |
| EV / EBITDAEnterprise value multiple | 10.55x | 68.79x | — | 100.94x | — |
| Price / SalesMarket cap ÷ Revenue | 2.85x | 13.56x | 4.93x | 14.37x | 2.61x |
| Price / BookPrice ÷ Book value/share | 2.73x | 6.43x | 2.82x | 10.94x | 3.67x |
| Price / FCFMarket cap ÷ FCF | 75.32x | 45.47x | 207.83x | 960.69x | — |
Profitability & Efficiency
ONTO leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
FORM delivers a 6.7% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-8 for ICHR. ONTO carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to IMOS's 0.61x. On the Piotroski fundamental quality scale (0–9), IMOS scores 6/9 vs ICHR's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.1% | +5.2% | -6.8% | +6.7% | -7.5% |
| ROA (TTM)Return on assets | +0.6% | +4.7% | -4.9% | +5.6% | -5.2% |
| ROICReturn on invested capital | +3.6% | +5.7% | -5.7% | +5.4% | -3.9% |
| ROCEReturn on capital employed | +3.4% | +6.5% | -5.9% | +6.1% | -4.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 4 | 4 | 3 |
| Debt / EquityFinancial leverage | 0.61x | 0.01x | 0.46x | 0.04x | 0.28x |
| Net DebtTotal debt minus cash | -$63M | -$329M | $132M | -$58M | $87M |
| Cash & Equiv.Liquid assets | $15.2B | $346M | $227M | $103M | $98M |
| Total DebtShort + long-term debt | $15.2B | $17M | $359M | $45M | $186M |
| Interest CoverageEBIT ÷ Interest expense | 6.24x | — | -168.82x | 252.69x | -5.97x |
Total Returns (Dividends Reinvested)
FORM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ONTO five years ago would be worth $41,263 today (with dividends reinvested), compared to $12,218 for COHU. Over the past 12 months, FORM leads with a +387.8% total return vs ONTO's +118.9%. The 3-year compound annual growth rate (CAGR) favors FORM at 72.9% vs COHU's 12.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +94.6% | +65.2% | +92.9% | +144.4% | +249.0% |
| 1-Year ReturnPast 12 months | +251.8% | +118.9% | +199.7% | +387.8% | +329.1% |
| 3-Year ReturnCumulative with dividends | +146.7% | +218.0% | +40.7% | +417.3% | +151.1% |
| 5-Year ReturnCumulative with dividends | +98.5% | +312.6% | +22.2% | +273.9% | +28.9% |
| 10-Year ReturnCumulative with dividends | +301.1% | +1431.7% | +330.2% | +1952.2% | +629.1% |
| CAGR (3Y)Annualised 3-year return | +35.1% | +47.1% | +12.1% | +72.9% | +35.9% |
Risk & Volatility
IMOS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IMOS is the less volatile stock with a 1.36 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IMOS currently trades 98.3% from its 52-week high vs ONTO's 86.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.36x | 2.66x | 2.13x | 2.02x | 3.93x |
| 52-Week HighHighest price in past year | $60.47 | $315.86 | $50.68 | $159.09 | $72.87 |
| 52-Week LowLowest price in past year | $15.06 | $85.88 | $15.34 | $26.08 | $13.12 |
| % of 52W HighCurrent price vs 52-week peak | +98.3% | +86.8% | +93.7% | +90.9% | +97.7% |
| RSI (14)Momentum oscillator 0–100 | 70.5 | 61.0 | 75.5 | 66.5 | 66.9 |
| Avg Volume (50D)Average daily shares traded | 65K | 832K | 953K | 1.6M | 795K |
Analyst Outlook
ICHR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: IMOS as "Hold", ONTO as "Buy", COHU as "Buy", FORM as "Hold", ICHR as "Buy". Consensus price targets imply 12.5% upside for ONTO (target: $308) vs -30.1% for ICHR (target: $50). IMOS is the only dividend payer here at 1.92% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $308.33 | $49.75 | $123.38 | $49.80 |
| # AnalystsCovering analysts | 1 | 11 | 14 | 19 | 14 |
| Dividend YieldAnnual dividend ÷ price | +1.9% | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | — | 0 | — | 1 |
| Dividend / ShareAnnual DPS | $35.67 | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.6% | +0.3% | +0.2% | 0.0% |
IMOS leads in 2 of 6 categories (Valuation Metrics, Risk & Volatility). ONTO leads in 1 (Profitability & Efficiency). 1 tied.
IMOS vs ONTO vs COHU vs FORM vs ICHR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IMOS or ONTO or COHU or FORM or ICHR a better buy right now?
For growth investors, Cohu, Inc.
(COHU) is the stronger pick with 12. 7% revenue growth year-over-year, versus 1. 8% for Onto Innovation Inc. (ONTO). ChipMOS TECHNOLOGIES Inc. (IMOS) offers the better valuation at 48. 2x trailing P/E (0. 8x forward), making it the more compelling value choice. Analysts rate Onto Innovation Inc. (ONTO) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IMOS or ONTO or COHU or FORM or ICHR?
On trailing P/E, ChipMOS TECHNOLOGIES Inc.
(IMOS) is the cheapest at 48. 2x versus FormFactor, Inc. at 209. 7x. On forward P/E, ChipMOS TECHNOLOGIES Inc. is actually cheaper at 0. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ChipMOS TECHNOLOGIES Inc. wins at 0. 01x versus Onto Innovation Inc. 's 1. 12x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — IMOS or ONTO or COHU or FORM or ICHR?
Over the past 5 years, Onto Innovation Inc.
(ONTO) delivered a total return of +312. 6%, compared to +22. 2% for Cohu, Inc. (COHU). Over 10 years, the gap is even starker: FORM returned +1952% versus IMOS's +301. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IMOS or ONTO or COHU or FORM or ICHR?
By beta (market sensitivity over 5 years), ChipMOS TECHNOLOGIES Inc.
(IMOS) is the lower-risk stock at 1. 36β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 190% more volatile than IMOS relative to the S&P 500. On balance sheet safety, Onto Innovation Inc. (ONTO) carries a lower debt/equity ratio of 1% versus 61% for ChipMOS TECHNOLOGIES Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IMOS or ONTO or COHU or FORM or ICHR?
By revenue growth (latest reported year), Cohu, Inc.
(COHU) is pulling ahead at 12. 7% versus 1. 8% for Onto Innovation Inc. (ONTO). On earnings-per-share growth, the picture is similar: Cohu, Inc. grew EPS -6. 7% year-over-year, compared to -140. 6% for Ichor Holdings, Ltd.. Over a 3-year CAGR, FORM leads at 1. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IMOS or ONTO or COHU or FORM or ICHR?
Onto Innovation Inc.
(ONTO) is the more profitable company, earning 13. 6% net margin versus -16. 4% for Cohu, Inc. — meaning it keeps 13. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ONTO leads at 13. 2% versus -13. 3% for COHU. At the gross margin level — before operating expenses — ONTO leads at 49. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IMOS or ONTO or COHU or FORM or ICHR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ChipMOS TECHNOLOGIES Inc. (IMOS) is the more undervalued stock at a PEG of 0. 01x versus Onto Innovation Inc. 's 1. 12x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ChipMOS TECHNOLOGIES Inc. (IMOS) trades at 0. 8x forward P/E versus 89. 2x for Cohu, Inc. — 88. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ONTO: 12. 5% to $308. 33.
08Which pays a better dividend — IMOS or ONTO or COHU or FORM or ICHR?
In this comparison, IMOS (1.
9% yield) pays a dividend. ONTO, COHU, FORM, ICHR do not pay a meaningful dividend and should not be held primarily for income.
09Is IMOS or ONTO or COHU or FORM or ICHR better for a retirement portfolio?
For long-horizon retirement investors, ChipMOS TECHNOLOGIES Inc.
(IMOS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 9% yield, +301. 1% 10Y return). Cohu, Inc. (COHU) carries a higher beta of 2. 13 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IMOS: +301. 1%, COHU: +330. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IMOS and ONTO and COHU and FORM and ICHR?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
IMOS pays a dividend while ONTO, COHU, FORM, ICHR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.